
Protein kinase inhibitor - Wikipedia
A protein kinase inhibitor (PKI) is a type of enzyme inhibitor that blocks the action of one or more protein kinases. [1] Protein kinases are enzymes that phosphorylate (add a phosphate, or PO …
A comprehensive review of protein kinase inhibitors for cancer …
There are several protein kinase inhibitors that have been approved by FDA in the last few decades. This article provides a review of the clinical benefits and side effect profiles of FDA …
Tyrosine Kinase inhibitors (TKIs): Uses & Side Effects
May 12, 2023 · Tyrosine kinase inhibitors (TKIs) are targeted therapies that treat many kinds of cancer. They block certain substances in cancerous cells that manage how fast the cells grow …
Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical …
Oct 8, 2021 · The central role of dysregulated kinase activity in the etiology of progressive disorders, including cancer, has fostered incremental efforts on drug discovery programs over …
Protein Kinase Inhibitors - PubMed
Nov 13, 2024 · The kinase inhibitors are a large group of unique and potent antineoplastic agents which specifically target protein kinases that are altered in cancer cells and that account for …
What is a Kinase Inhibitor? - News-Medical.net
Jul 20, 2023 · Tyrosine kinase inhibitors are particularly important agents because these high-affinity cell surface receptors play a critical role in the progression of many cancers. Tyrosine …
Definition of kinase inhibitor - NCI Dictionary of Cancer Terms
Some kinase inhibitors are used to treat cancer. A substance that blocks a type of enzyme called a kinase. Human cells have many different kinases, and they help control important functions, …
Kinase inhibitors: A deep dive into JAKs, TKIs, and other classes
Mar 26, 2025 · Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
Protein Kinase Inhibitors - LiverTox - NCBI Bookshelf
Nov 13, 2024 · The kinase inhibitors are a large group of unique and potent antineoplastic agents which specifically target protein kinases that are altered in cancer cells and that account for …
Kinase-targeted cancer therapies: progress, challenges and …
Feb 19, 2018 · These kinase inhibitors have achieved a significant increase in patient survival rate in myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), thus translating basic …